Selkirk Pharma announces new APS qualified facility with advanced fill/finish capacity in Spokane, WA

De­spite a failed con­fir­ma­to­ry tri­al an­nounced in Oc­to­ber, the FDA’s Pe­ter Marks, the top reg­u­la­tor for all cell and gene ther­a­pies in the US, is

Bris­tol My­ers Squibb is re­lat­ing space ex­plor­ers, deep sea ocean divers and ex­treme moun­tain climbers to its own “un­seen ex­plor­ers” in a new cor­po­rate brand